A Study Of Maraviroc In HIV Co-Infected Subjects With Hepatitis C And/Or Hepatitis B

PHASE4CompletedINTERVENTIONAL
Enrollment

138

Participants

Timeline

Start Date

May 18, 2011

Primary Completion Date

April 23, 2013

Study Completion Date

March 24, 2015

Conditions
HIV Coinfection
Interventions
DRUG

Maraviroc

150mg, 300mg or 600mg twice daily x 144 weeks; dosing dependent on components of the current suppressive anti-HIV therapy

DRUG

Placebo

150mg, 300mg or 600mg twice daily x 144 weeks; dosing dependent on components of the current suppressive anti-HIV therapy

Trial Locations (48)

1097

Egyesített Szent István és Szent László Kórház Rendelőintézet, Budapest

10029

Icahn School of Medicine at Mount Sinai, New York

Mount Sinai Faculty Practice Associates, New York

The Mount Sinai Hospital, New York

10595

New York Medical College, Valhalla

12157

EPIMED - Gesellschaft fuer epidemiologische und klinische Forschung in der Medizin mbH, Berlin

14004

Hospital Reina Sofia Hospital Provincial, Córdoba

20099

ifi - Studien und Projekte GmbH, Hamburg

20246

Universitaetsklinikum Hamburg-Eppendorf, Hamburg

28029

Hospital Carlos Iii, Madrid

28209

I.D. Consultants, P.A., Charlotte

30912

Georgia Regents Medical Center, Augusta

33137

Community AIDS Resource Inc dba Care Resource, Miami

33305

Rowan Tree Medical, P.A., Wilton Manors

33602

University of South Florida Health - HIV Clinical Research Unit, Tampa

41014

Hospital Nuestra Señora de Valme, Seville

46014

Consorcio Hospital General Universitario de Valencia, Valencia

48202

Henry Ford Hospital, Detroit

50937

Klinikum der Universitaet zu Koeln, Cologne

52242

University of Iowa Hospitals and Clinics, Iowa City

53127

Universitaetsklinikum Bonn, Immunologische Ambulanz HIV, Bonn

69317

Hopital de la Croix Rousse, Lyon

75020

Hopital Tenon, Service des Maladies Infectieuses, Paris

75219

Southwest Infectious Disease Clinical Research Inc., Dallas

75235

University of Texas Southwestern Medical Center at Dallas, Dallas

75679

Centre Hospitalier Cochin Saint Vincent de Paul, Paris

78207

University Health Care Center Downtown, San Antonio

80336

Ludwig-Maximilians-Universitaet, München

90015

AIDS Research Alliance, Los Angeles

93301

The Office of Dr. Franco Antonio Felizarta, M.D., Bakersfield

94110

University of California, San Francisco - Hepatitis/HIV Clinical Trials Group (HHCTG), San Francisco

94115

University of California, San Francisco - Mt. Zion Hospital, San Francisco

94602

Alameda Health System - Highland Hospital, Oakland

95811

University of California Davis Research, Sacramento

95817

University of California, Sacramento

97015

Kaiser Permanente Sunnybrook Medical Office, Clackamas

97227

Kaiser Permanente Northwest, Portland

07102

Saint Michael's Medical Center, Newark

625 00

Fakultni nemocnice Brno, Brno

50-220

EMC Instytut Medyczny S.A. Przychodnia przy ul. Lowieckiej, Wroclaw

85-030

Wojewodzki Szpital Obserwacyjno - Zakazny im. Tadeusza Browicza w Bydgoszczy, Bydgoszcz

01-201

SPZOZ Wojewodzki Szpital Zakazny, Warsaw

00935

Farmacia UPR-CTU, San Juan

University of Puerto Rico - School of Medicine, San Juan

00717-1567

Ararat Research Center, Ponce

08035

Hospital Universitari Vall dHebron, Barcelona

SE1 7EH

Harrison Wing Research Office, Guys and St. Thomas NHS Foundation Trust, London

SW10 9NH

St Stephen's AIDS Trust, London

Sponsors

Lead Sponsor

Collaborators (1)

All Listed Sponsors
collaborator

Pfizer

INDUSTRY

lead

ViiV Healthcare

INDUSTRY